SynthesisCancer immunology, immunotherapy : CII2021

Sarcopenia and the risk of adverse events in patients treated with immune checkpoint inhibitors: a systematic review.

Yuli Guzman-Prado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.